New oxabispidine compounds useful in the treatment of cardiac arrhythmias
申请人:Bjore Annika
公开号:US20060166979A1
公开(公告)日:2006-07-27
There is provided compounds of formula I,
wherein R
1
, R
2
, R
3
, R
4
, R
41
to R
46
, A, B and G have meanings given in the description, which are useful in the prophylaxis and in the treatment of arrhythmias, in particular atrial and ventricular arrhythmias.
Oxabispidine compounds useful in the treatment of cardiac arrhythmias
申请人:Bjore Annika
公开号:US20070117799A1
公开(公告)日:2007-05-24
There is provided compounds of formula I,
wherein R
1
, R
2
, R
3
, R
4
, R
41
to R
46
, A, B and G have meanings given in the description, which are useful in the prophylaxis and in the treatment of arrhythmias, in particular atrial and ventricular arrhythmias.
New oxabispidine compunds useful in the treatment of cardiac arrhythmias
申请人:Bjore Annika
公开号:US20090326221A1
公开(公告)日:2009-12-31
There is provided compounds of formula I,
wherein R
1
, R
2
, R
3
, R
4
, R
41
to R
46
, A, B and G have meanings given in the description, which are useful in the prophylaxis and in the treatment of arrhythmias, in particular atrial and ventricular arrhythmias.
Hydrochinondiether, Verfahren zu ihrer Herstellung und ihre Verwendung zur Schädlingsbekämpfung
申请人:BASF Aktiengesellschaft
公开号:EP0486804A2
公开(公告)日:1992-05-27
Hydrochinondiether der allgemeinen Formel I,
in der die Substituenten folgende Bedeutung haben:
A¹, A²
ggf. subst. Alkylen;
R¹
Wasserstoff, Halogen oder Alkyl;
R²
ggf. subst. Pyrazol oder Pyridyl;
X
ggf. subst. fünfgliedriger Heteroaromat,
Verfahren zu ihrer Herstellung und dafür verwendete Zwischenprodukte sowie die Verwendung der Verbindungen I.
通式 I 的对苯二酚二乙醚、
其中取代基的含义如下:
A¹、A²
可能是亚亚烷基;
R¹
氢、卤素或烷基;
R²
必要时为亚基吡唑或吡啶基;
X
任选取代的五元杂芳基、
化合物 I 的制备工艺、中间体及其用途。
Oxabispidine compounds useful in the treatment of cardiac arrythmias
申请人:AstraZeneca AB
公开号:EP1559717A2
公开(公告)日:2005-08-03
The present invention relates to a combination comprising component (a) being a compound of formula I,
and component (b), being, at least one other drug useful in the treatment of arrhythmias and / or at least one other drug useful in the treatment of a cardiovascular disorder.